Background Invasive fungal disease (IFD) is an important problem complicating the therapy
of haematologic patients. Aim This study aimed to provide data on the epidemiology of IFD …

This study investigated the epidemiology and risk factors associated with invasive fungal
infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly …

Despite the recent introduction of mold-active antifungal prophylaxis (MAP), breakthrough
invasive fungal infections (b-IFI) still represent a possible complication and a cause of …

Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in
immunocompromised patients. Patients with hematological malignancies undergoing …

Invasive fungal infections (IFIs) represent an important cause of morbidity and mortality in
patients affected by hematological malignancies (HMs), particularly those with an …

Background/aim: Invasive fungal infection (IFI) causes morbidity and mortality among
patients with hematological malignancies. We evaluated the incidence and treatment …

Objectives Antifungal prophylaxis is recommended for haematological patients at high risk of
invasive fungal infections (IFIs). Incidence, optimal therapeutic management and outcome of …

Background Invasive fungal infection (IFI) causes significant morbidity and mortality in
patients with hematological malignancies, especially those with acute myeloid leukemia …

Objectives We describe the current epidemiology, causes, and outcomes of breakthrough
invasive fungal infections (BtIFI) in patients with haematologic malignancies. Methods BtIFI …

There are concerns that the financial crisis in Greece negatively affected the management of
invasive fungal infections (IFIs) among patients with hematological malignancies (HM). A …